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ABSTRACT
Childhood chronic kidney disease (CHD) poses multiple threats to bone accrual; however, the associated
fracture risk is not well characterized. This prospective cohort study included 537 CKD in Children (CKiD)
participants. Fracture histories were obtained at baseline, at years 1, 3, and 5 through November 1, 2009, and
annually thereafter. We used Cox regression analysis of ﬁrst incident fracture to evaluate potential correlates of
fracture risk. At enrollment, median age was 11 years, and 16% of patients reported a prior fracture. Over a
median of 3.9 years, 43 males and 24 females sustained incident fractures, corresponding to 395 (95%
conﬁdence interval [95% CI], 293–533) and 323 (95% CI, 216–481) fractures per 10,000 person-years, respectively. These rates were 2- to 3-fold higher than published general population rates. The only gender difference in
fracture risk was a 2.6-fold higher risk in males aged $15 years (570/10,000 person-years, adjusted P=0.04). In
multivariable analysis, advanced pubertal stage, greater height Z-score, difﬁculty walking, and higher average
log-transformed parathyroid hormone level were independently associated with greater fracture risk (all
P#0.04). Phosphate binder treatment (predominantly calcium-based) was associated with lower fracture risk
(hazard ratio, 0.37; 95% CI, 0.15–0.91; P=0.03). Participation in more than one team sport was associated with
higher risk (hazard ratio, 4.87; 95% CI, 2.21–10.75; P,0.001). In conclusion, children with CKD have a high burden
of fracture. Regarding modiﬁable factors, higher average parathyroid hormone level was associated with greater
risk of fracture, whereas phosphate binder use was protective in this cohort.
J Am Soc Nephrol 27: 543–550, 2016. doi: 10.1681/ASN.2015020152

Childhood CKD is associated with nearly universal disturbances in bone and mineral metabolism, collectively termed chronic kidney
disease–mineral and bone disorder (CKD-MBD),
that present multiple obstacles to bone accrual. In
addition to secondary hyperparathyroidism and
abnormal mineral metabolism (hyperphosphatemia,
hypocalcemia, vitamin D deﬁciency, and decreased 1-a-hydroxylation of 25-hydroxyvitamin
D [25(OH)D]), CKD is associated with delayed
pubertal maturation, growth failure, abnormalities in the growth hormone axis, malnutrition,
J Am Soc Nephrol 27: 543–550, 2016

acidosis, and muscle deﬁcits.1–6 Treatment with
glucocorticoids may further compromise bone
health. The resultant deﬁcits in bone density and
Received February 10, 2015. Accepted April 29, 2015.
Published online ahead of print. Publication date available at
www.jasn.org.
Correspondence: Michelle R. Denburg, The Children’s Hospital
of Philadelphia, Perelman School of Medicine at the University of
Pennsylvania, 34th Street and Civic Center Blvd, PA 19104.
Email: denburgm@Email.chop.edu
Copyright © 2016 by the American Society of Nephrology

ISSN : 1046-6673/2702-543

543

CLINICAL EPIDEMIOLOGY

www.jasn.org

micro-architecture likely impact short- and long-term
fracture risk. 7
It is well established that adults with ESRD have a substantially increased risk of fracture and associated morbidity
and mortality.8–17 In a study using the United States Renal
Data System, Alem et al. found that compared with healthy
controls, young adults on hemodialysis had a 100-fold higher
hip fracture rate.9 In a population-based Dutch cohort of 247
adults with a history of ESRD at #14 years of age, 89% had
osteopenia, 37% had clinical symptoms of bone disease, and
18% were disabled by bone disease.18 Similarly, adults with a
history of renal transplantation in childhood reported high
rates of fracture.19 Several studies have extended these observations to adults with moderate CKD.20–31
Until recently, studies in children were limited to a report
in solid organ transplant recipients, demonstrating a 6-fold
higher incidence of all fractures and 160-fold higher incidence
of vertebral fractures.32 We subsequently completed a study in
170 children and adolescents with CKD and ESRD. Over an
average follow-up of 1 year, 6.5% of participants sustained a
fracture (incidence of 556/10,000 person-years), and lower
baseline cortical volumetric bone mineral density (BMD)
was associated with risk of subsequent fracture.1 The sample
size and follow-up duration were insufﬁcient to deﬁne genderspeciﬁc incidence and identify risk factors for fracture. To our
knowledge, no other data are available in children with CKD.
The large prospective Chronic Kidney Disease in Children
(CKiD) cohort study represents a unique resource to evaluate
fracture burden in pediatric CKD. The study objectives were
to determine the gender-speciﬁc incidence of fracture in
CKiD and to identify risk factors for fracture in this high-risk
population.

RESULTS
Fracture Incidence

Participant characteristics at enrollment (Table 1) were representative of the full CKiD cohort.3,33 At enrollment, 16% had a
history of prior fracture. Over a median follow-up of 3.9 years
(interquartile range 1.8–4.9), 67 participants reported an incident fracture, representing a cumulative incidence of 12.5%. Of
these, 43 fractures occurred among males and 24 among females, corresponding to rates of 395 (95% conﬁdence interval
[95% CI], 293–533) and 323 (95% CI, 216–481) per 10,000
person-years, respectively. The median age at ﬁrst incident fracture was 15 years in males and 13 years in females. Table 2 shows
fracture incidence stratiﬁed by age and gender. Males $15 years
of age had the highest fracture rate of 570/10,000 person-years.
Fracture Sites

For 17 (25%) of the 67 incident fracture events, a speciﬁc
fracture site was not recorded. The distribution of fracture sites
differed signiﬁcantly by gender (P=0.03, Table 3). In females,
fractures of the ankle/foot were most common, accounting for
544
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Table 1. Baseline cohort characteristics
Characteristic

N (%) or median (IQR)

N

Age (years)
Male gender
Black race
Hispanic
Tanner stage
1
2
3
4
5
Height Z-score
Body mass index Z-score
eGFR (ml/min 1.73 m2)
CKD stage
1/2
3
4/5
CKD duration (years)
Glomerular etiology
Autoimmune disease
Prematurity
Walking difﬁculty
Medications
Vitamin/mineral supplement
Nutritional vitamin D supplement
Activated vitamin D
Phosphate binder
Alkali therapy
Growth hormone
Diuretic
Corticosteroid
Albumin (g/dl)
Corrected calcium (mg/dl)
Phosphorus (mg/dl)
Parathyroid hormone (pg/ml)
25-hydroxyvitamin D
[25(OH)D, ng/ml]
Vitamin D deﬁciency
[25(OH)D ,20 ng/ml]
FGF23 (RU/ml)

11.0 (7.4, 14.5)
326 (61)
116 (22)
76 (14)

537
537
537
531
514

307 (60)
49 (10)
42 (8)
72 (14)
44 (9)
20.7 (21.4, 0.1)
0.4 (20.4, 1.2)
46.5 (34.4, 58.5)
119 (22)
325 (61)
87 (16)
8.5 (4.4, 12.9)
110 (20)
14 (3)
65 (13)
64 (12)
122 (23)
27 (5)
191 (36)
102 (19)
152 (28)
60 (11)
34 (6)
36 (7)
4.3 (4.1, 4.5)
9.4 (9.1, 9.6)
4.5 (4.0, 5.0)
48.2 (28.5, 83.1)
28.3 (19.1, 35.1)

523
521
531
531

531
537
530
519
532
537

533
533
525
379
388

105 (27)
131.2 (87.9, 197.9)

388

IQR, interquartile range.

26% of fractures. In males, fractures of the wrist/hand and
arm/elbow were most common, together accounting for
33% of fractures.
Correlates of Incident Fracture

The covariates with P,0.2 when individually assessed in a base
Cox regression model including age, gender, and their interaction were: Tanner stage, height Z-score, baseline eGFR,60
ml/min per 1.73 m2, phosphate binder use, calciferol supplementation, history of head injury, and both baseline and average
concentrations of log-transformed parathyroid hormone
(lnPTH) and 25(OH)D. In addition to these covariates, black
race, prematurity, and baseline walking difﬁculty were also
considered in multivariable regression, because of a priori
J Am Soc Nephrol 27: 543–550, 2016
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Table 2. Fracture incidence by age and gender
Female
Male

Age (Years)

Person-Time (Person-Years)

Fractures (n)

Incidence (Per 10,000 Person-Years)

95% CI

,15
$15
,15
$15

456
289
720
368

17
7
22
21

373
242
306
570

(232, 600)
(116, 509)
(201, 464)
(372, 874)

Table 3. Distribution of fracture site by gender
Site

Female
n (%)

Male
n (%)

Shoulder
Arm/elbow
Wrist/hand
Finger
Hip
Leg/knee
Ankle/foot
Toe
Collar bone
Rib
Back
Unspeciﬁed
Totala

0 (0)
2 (7.4)
0 (0)
3 (11.1)
1 (3.7)
1 (3.7)
7 (25.9)
3 (11.1)
1 (3.7)
0 (0)
1 (3.7)
8 (29.6)
27 (100)

1 (2.2)
7 (15.6)
8 (17.8)
5 (11.1)
0 (0)
5 (11.1)
6 (13.3)
0 (0)
3 (6.7)
1 (2.2)
0 (0)
9 (20)
45 (100)

a
The total n exceeds 67 ﬁrst fracture events as there were fractures involving
multiple sites.

hypotheses regarding their impact on fracture risk. Body
mass index Z-score, log-transformed ﬁbroblast growth factor
23 (FGF23) level, active vitamin D therapy, and corticosteroid
exposure were not associated with fracture when individually
assessed in the base Cox regression model of age, gender, and
their interaction (all P.0.4). Figure 1 shows the ﬁnal multivariable Cox regression model arrived at using both backward
and forward selection. There was a statistically signiﬁcant interaction between age and gender; there was no gender difference in fracture risk below 15 years of age, but being a male
$15 years of age was associated with a 2.6-fold higher fracture
risk, compared with a female $15 years. Tanner stage, height
Z-score, walking difﬁculty, lnPTH, and phosphate binder use
remained independent correlates of fracture risk in multivariable analysis. There was a 25% higher risk per standard
deviation greater height Z-score. Advanced pubertal stage
(Tanner 4–5 versus 1–3) and walking difﬁculty were both
associated with a more than 2-fold greater risk of fracture.
There was a 50% higher risk associated with each unit greater
average lnPTH. Substituting baseline for average lnPTH yielded similar results with a hazard ratio (HR) of 1.50 (95% CI,
1.04–2.15; P=0.03). Phosphate binder use was protective,
with a 63% lower hazard of fracture. Approximately 20% of
the cohort was on a binder at each visit, and the majority of
this phosphate binder use was calcium-based (median 82%;
Supplemental Table 1). Substituting use of a calcium-containing
binder and/or vitamin for any phosphate binder was similarly
J Am Soc Nephrol 27: 543–550, 2016

protective in the ﬁnal multivariable Cox model (HR, 0.37; 95%
CI, 0.17–0.82, P=0.02). At each visit, there was no difference in
the serum concentrations of corrected calcium among participants who were taking as compared with those who were not
taking a phosphate binder, while serum phosphorus at most
visits was signiﬁcantly higher in those on a phosphate binder
compared with those not on a phosphate binder (Supplemental
Table 2). With the exception of year 4, PTH concentration did
not differ by phosphate binder use. Without adjusting for PTH
in the model, having a baseline eGFR,60 was associated with
a HR of 2.43 (P=0.02); this was attenuated to 2.08 (P=0.09) after
adjustment for average lnPTH. Race, history of prevalent
fracture, prematurity, underlying glomerular versus nonglomerular disease, CKD duration, and serum concentrations
of calcium, phosphorus, and 25(OH)D were not independent
risk factors for fracture.
While the availability of physical activity data were limited
to participants $12 years of age, when these measures were
assessed in the ﬁnal multivariable model derived from analysis of the full cohort, participation in a greater number of
team sports was independently associated with higher fracture risk (Table 4). Participation in .1 sport was associated
with a nearly 5-fold higher risk of facture (HR, 4.87; 95% CI,
2.21–10.75; P,0.001). Participation in $1 team sport was
associated with a HR of 2.35 (95% CI, 1.01–5.47; P=0.047).
The substantial reduction in sample size attenuated the effect
of other covariates; however, the strong protective effect of
phosphate binder use persisted, with a HR of 0.12 (95% CI,
0.01–0.91; P=0.04). At each visit when physical activity was
assessed, height Z-score was positively associated with the
number of team sports in the prior 12 months (spearman’s
Rho=0.14–0.23, all P#0.03). The median height of the participants who played .1 team sport was closer to the 50th percentile
as compared with those who participated in #1 team sport for
whom the median height was consistent with that of the entire
cohort around the 25th percentile (Figure 2).

DISCUSSION

This is the ﬁrst study to evaluate the burden of fracture risk
in a large prospective cohort of children with CKD. Numerous studies have demonstrated increased fracture rates in
adults with ESRD8–17 and CKD.20–31 With 90% of peak skeletal mass accrued by age 18, children with CKD are uniquely
vulnerable to its multiple threats to bone health, but the
Fracture Burden in the CKiD Cohort

545

CLINICAL EPIDEMIOLOGY

www.jasn.org

The observed fracture rates of 395/
10,000 person-years for males and 323/
10,000 person-years for females in CKiD
were 2.4- and 3-fold higher, respectively
than gender-speciﬁc rates of 162/10,000
person-years and 103/10,000 person-years
reported in a large population-based study
of fracture epidemiology in children and
adolescents.34 Considering their 95% CIs,
the observed fracture rates in Table 2 were
1.8- to 3.3-fold higher in males and 2.1- to
4.7-fold higher in females, suggesting that
the relative impact of CKD may be greater
among females. Consistent with fracture
epidemiology in the general population,
incidence varied with age and gender,
with males $15 years of age having the
highest incidence of 570/10,000 personyears, which was again 2-fold higher than
previously reported peak incidence in 14–
15-year-old males (274–282/10,000 personyears).34 Although as expected teenage males
had the highest rate of fracture, the fact that
the rate of fracture in females ,15 years of
age (373/10,000 person-years) far surpassed the peak incidence in the general
teenage male population speaks to the
possible greater relative risk in females.
To underscore the burden of fracture in
this population, the observed rates for
Figure 1. Final multivariable Cox regression model: correlates of incident fracture. both genders in the CKiD cohort exceeded
a
HR for males $15 years versus females $15 years=(3.94*0.67)=2.6. bPTH natural
that reported in 12,782 adult hemodialysis
log transformed.
patients (256/10,000 person-years). 14
The higher overall incidence (556/10,000
Table 4. Final multivariable Cox regression model:
person-years) in our prior smaller pediatric study1 was likely
correlates of incident fracture, including measures of physical
attributable to the inclusion of participants (30%) with
activity
ESRD.
Model n=290 (483 observations)
HR
95% CI
P Value
We identiﬁed several signiﬁcant and independent factors
Age $15 versus ,15 years
0.39 (0.10, 1.49)
0.17
associated with higher incident fracture, including baseline
Male
0.40 (0.12, 1.36)
0.14
walking difﬁculty, Tanner stage 4–5, greater height Z-score,
Age X male interaction
3.89 (0.72, 21.04)
0.12
higher average PTH, and competitive sports participation.
Tanner stages 4–5 versus 1–3
1.42 (0.58, 3.52)
0.45
Phosphate binder use was the only independent protective
Height Z-score
1.17 (0.89, 1.55)
0.25
factor identiﬁed. We previously reported that secondary hy2
Baseline eGFR,60 ml/min per 1.73 m 2.46 (0.71, 8.50)
0.15
perparathyroidism was associated with declines in peripheral
Baseline walking difﬁculty
1.07 (0.15, 7.69)
0.95
quantitative computed tomography measures of cortical BMD
On phosphate binder
0.12 (0.01, 0.91)
0.04
a
in childhood CKD,1,5 as anticipated given the high bone turnAverage lnPTH
1.19 (0.68, 2.06)
0.54
over state of hyperparathyroidism.35 Cross-sectional bone
.1 sports team in past 12 months
4.87 (2.21, 10.75) ,0.001
a
histomorphometry studies in children demonstrated that
PTH natural log transformed.
defective mineralization was present as early as stage 2
CKD, and the prevalence increased with progressive CKD
study of fractures in this population has been hampered by severity, exceeding 90% in CKD 5D.36 In children on peria dearth of large prospective studies. The strengths of the
toneal dialysis, this mineralization defect persisted after
CKiD cohort allowed us to deﬁne gender-speciﬁc fracture
therapy with active vitamin D.37 In children with pre-dialysis
incidence and identify multiple speciﬁc risk factors in pediatric CKD, lower serum calcium and higher PTH concentrations
CKD.
were associated with defective mineralization. 36 Taken
546
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Figure 2. Relationship between height and sports participation.

together, these ﬁndings suggest that hyperparathyroidism
contributes to increased fracture risk in children with CKD
via impaired mineralization.
The ﬁnding of phosphate binder use being protective with a
.60% lower fracture risk in multivariable analysis, even more
so among the adolescent subset of the cohort with physical
activity data, is provocative and warrants further investigation.
Given the demonstrated association of lower serum calcium
with defective mineralization36 and that the majority of phosphate binder use in CKiD was calcium-based, we hypothesize
that the protective effect may be due to calcium supplementation; indeed, substituting use of a calcium-containing
binder and/or vitamin was similarly protective in the ﬁnal
multivariable Cox model, with a 63% lower fracture risk.
This is supportive of our prior ﬁnding that serum calcium
was an independent correlate of cortical BMD, particularly in
the growing skeleton.1 Furthermore, the protective effect of
phosphate binder use was clearly not related to a beneﬁcial
effect on serum phosphorus or FGF23 given that neither was
associated with fracture and that phosphorus concentrations
were higher in those taking versus not taking binders at most
visits. At a time of growing concerns about limiting calciumbased binder use due to associations with vascular calciﬁcation in adults, these data provide a cautionary note regarding
age-appropriate calcium requirements for optimal bone
health in children.38
Though not statistically signiﬁcant after adjustment for
PTH, the fully adjusted HR of 2.08 associated with a baseline
eGFR,60 ml/min per 1.73 m2 is highly consistent with ﬁndings in adults with CKD. In a recent study of .600,000 individuals $40 years of age,30 the incidence rate ratio for fracture
in 40–65-year-old year old men with an eGFR of 30–44 and
15–29 was 1.7 and 2.2, respectively, compared with the
J Am Soc Nephrol 27: 543–550, 2016
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reference group with eGFR$60. Similarly,
the rate ratio for fracture in 40–65-year-old
women was 2.4 for both an eGFR of 30–44
and eGFR of 15–29 versus eGFR$60. The
association with walking difﬁculty may be
due to increased risk of falls and osteopenia
from immobility. The strong independent
relationship with height Z-score was an interesting ﬁnding. Childhood CKD is associated with a substantial burden of growth
failure and short stature,39 supported by
the median height Z-score of -0.7, with
16% of the cohort below the 3rd percentile.
A recent CKiD study found a signiﬁcant
association between catch-up growth and
parental report of physical functioning.40
Consistent with this, we found that greater
height Z-score was related to greater participation in team sports, which was a strong
independent correlate of fracture risk. The
attenuation of the association of height Zscore with fracture risk in the multivariable
analysis including team sports participation may have been due
in part to the smaller sample size, but the magnitude and statistical signiﬁcance of the association with team sports participation in this limited sample indicates that the association
with height Z-score was at least in part confounded by team
sports participation.
The study limitations are largely related to the fact that
prospective assessment of fracture outcomes was not an initial
aim of the CKiD study. While participants were asked at
study visits about interim fractures, the fracture date was not
recorded, and information regarding the mechanism of injury
was not collected. However, a prior population-based study
demonstrated that skeletal fragility contributed to fracture risk
in children, regardless of trauma severity.41 Since time between
visits was up to 1–2 years, censoring at the midpoint of this
interval may have created some misclassiﬁcation of time and
consequent imprecision in the observed incidence rates. This,
along with the fact that fracture events were not adjudicated
by radiology reports, likely biased the results to the null. Furthermore, the lower bound of the 95% CI for the observed
rates far surpassed general population rates. Fracture site was
not speciﬁed for 25% of the incident fracture events. Physical
activity assessments were only available in the adolescent subset of the cohort. However, the association with competitive
sports was robust. The etiology of the reported walking difﬁculty was not ascertained. BMI Z-score did not differ between
those with versus without walking difﬁculty. Finally, since
fractures were ascertained through questionnaire, incidence
of vertebral fractures, which are often subclinical, was likely
underestimated.
In summary, fracture rates in the CKiD cohort were 2- to
3-fold higher than population-based rates, with the greatest
burden among males at the time of peak fracture incidence
Fracture Burden in the CKiD Cohort
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(570/10,000 person-years). Independent modiﬁable factors
included PTH and phosphate binder use. Higher average PTH
concentration was associated with greater risk, while phosphate binder use was largely calcium-based and was protective.
Team sports participation was a signiﬁcant risk factor for
fracture. Future studies are needed to determine how to
optimize CKD-MBD management, including calcium requirements, for fracture prevention.

CONCISE METHODS
Study Design and Participants
We studied 537 children and adolescents with CKD from 48 North
American centers who enrolled in CKiD between 2005 and 2011;
CKiD methods have been published.42 Eligibility criteria included:
age 1–16 years, eGFR 30 to ,90 ml/min per 1.73 m2,43 no prior organ
transplantation, no diagnosis of malignancy or HIV within
12 months, and no history of structural heart disease, genetic syndromes involving the central nervous system, or severe cognitive disability. Participants were followed annually for up to 6 years. The
study adhered to the Declaration of Helsinki, and the Institutional
Review Boards of all participating sites approved the CKiD protocol.
Informed consent was obtained from a parent/guardian and assent/
consent from the participant.

Assessment of Fracture Outcome
Participants/guardians were asked whether the participant ever
had a fracture (prevalent fracture) at the baseline visit. They were
then interviewed at years 1, 3, and 5 regarding new (incident)
fractures in the interim since the prior visit (Supplemental Figure 1).
537 participants provided interval fracture histories and are included in this analysis of incident fractures. Fracture data were
available in 98% (n=518), 95% (n=372), and 97% (n=184) of
participants completing the year 1, year 3, and year 5 visits, respectively. After November 1, 2009 participants/guardians were interviewed at each annual visit about new fractures in the antecedent
year, so data on fracture occurrence were available for 17% (n=78),
87% (n=273), and 97% (n=60) of participants at years 2, 4, and 6,
respectively.

Assessment of CKD Characteristics and Risk Factors
Potential correlates of fracture included: age, gender, black versus nonblack race, Hispanic ethnicity; time-varying anthropometry (height
and body mass index Z-scores, Tanner stage); baseline comorbidities
with impact on bone health (prevalent fracture, prematurity, autoimmunity, walking difﬁculty, history of head injury, coma, or seizure);
CKD severity, duration, and glomerular versus non-glomerular
etiology; relevant medications (calciferol, active vitamin D, phosphate
binder, alkali therapy, corticosteroid); and biochemical markers of
mineral metabolism and nutrition (calcium, phosphorus, intact PTH,
FGF23, 25(OH)D, albumin).
For CKD severity, eGFR was estimated using the CKiD equation44
and examined both as a continuous and categorical exposure and as a
baseline and time-varying covariate. Medication usage was time548
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varying and categorical (on/off therapy at the time of visit). Calcium,
phosphorus, and albumin were time-varying and available for each
annual visit.45 Serum PTH and 25(OH)D and plasma C-terminal
FGF23 were ﬁrst measured 3–6 months after baseline in 379, 388,
and 388 participants, respectively, and then at alternating visits from
the second annual visit onwards45–47; both the baseline and average values were considered for PTH, FGF23, and 25(OH)D. Serum
calcium concentrations were corrected for albumin: corrected
calcium=measured calcium+0.83(4.02albumin).
Questions from the 2005 Youth Risk Behavior Survey were used to
assess physical activity in participants $12 years of age,48 including
measures of exercise-related sweating, non-sweat exercise, hours
watching television or playing video games/using computer, physical
education classes and duration, and the number of sports teams
played on in the past 12 months.

Analysis
Descriptive statistics were reported as median and interquartile range
for continuous variables and frequencies for categorical variables.
Group differences in continuous variables were assessed using the
t-test or Wilcoxon rank-sum test as appropriate and categorical variables using the chi-squared test. PTH and FGF23 levels were skewed
and, therefore, natural log transformed.
Data were censored at the last visit with available fracture data. For
the assessment of fracture incidence, follow-up time was censored at
the midpoint of the interval between the visit at which the ﬁrst incident
fracture was reported and the antecedent visit. As time between visits
was up to 1–2 years, censoring at the midpoint of this interval ensured
that on average, the time of fracture was closer to when the fracture
was actually sustained. Multivariable Cox proportional hazards regression was used to evaluate the potential correlates of fracture delineated above. The robust standard error option was used to limit
misspeciﬁcation.49
Prior population-based studies reported greater fracture rates in
adolescent males; therefore, we examined multiplicative interactions
between age and gender. For regression analyses, all covariates were
individually assessed in a base model including age $15, gender, and
their interaction. Covariates with a P value ,0.2 were considered in
the multivariable regressions using both forward and backward stepwise selection approaches. Covariates with adjusted P value ,0.1 were
retained in the ﬁnal model. Physical activity measures were available in
the subset $12 years old at baseline and years 1, 3, and 5 and were tested
in the ﬁnal multivariable Cox model including variables derived from
analysis of the full cohort. A two-sided P value of ,0.05 was considered
statistically signiﬁcant. Analyses were performed using STATA 13.0 software (Stata Corporation, College Station, TX).
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